Skip to main content
. 2019 Jul 10;28:100901. doi: 10.1016/j.rmcr.2019.100901

Fig. 2.

Fig. 2

An EGFR exon 19 deletion was accurately scored using the therascreen® assay (upper panel). Manual review of the cancer hotspot NGS data revealed this deletion at 0.8% allele fraction (lower panel).